The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis.
Nrf2-HMOX1通路作为治疗靶点,可通过抑制铁死亡逆转非小细胞肺癌的顺铂耐药性
期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02564-z
Zuo Ling, Zou Xinru, Ge Jia, Hu Shuning, Fang Yixuan, Xu Yi, Chen Rui, Xu Sheng, Yu Guangyang, Zhou Xiaorong, Ji Lili